Overview
Hidenobu Suzuki practices in Tokyo, Japan. Suzuki is highly rated in 2 conditions, according to our data. Their top areas of expertise are Schizophrenia, Neurotoxicity Syndromes, Insomnia, and Drug Induced Dyskinesia.
Their clinical research consists of co-authoring 51 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- SchizophreniaSuzuki isDistinguished. Learn about Schizophrenia.
- Advanced
- Neurotoxicity SyndromesSuzuki isAdvanced. Learn about Neurotoxicity Syndromes.
- Experienced
- Alzheimer's DiseaseSuzuki isExperienced. Learn about Alzheimer's Disease.
- DementiaSuzuki isExperienced. Learn about Dementia.
- Drug Induced DyskinesiaSuzuki isExperienced. Learn about Drug Induced Dyskinesia.
- HypotoniaSuzuki isExperienced. Learn about Hypotonia.
- InsomniaSuzuki isExperienced. Learn about Insomnia.
- Movement DisordersSuzuki isExperienced. Learn about Movement Disorders.